The Role of Interstitial Brachytherapy in Multimodality Management of Solid Tumors
Authors:
R. Soumarová 1; L. Homola 1; H. Perková 1; S. Czudek 2; M. Škrovina 2; L. Adamčík 2
Authors‘ workplace:
Onkologické centrum J. G. Mendela, Nový Jičín, primář: MUDr. R. Soumarová, Ph. D.
1; Chirurgické oddělení, Nemocnice Nový Jičín, primář: MUDr. S. Czudek, CSc.
2
Published in:
Rozhl. Chir., 2007, roč. 86, č. 10, s. 533-539.
Category:
Monothematic special - Original
Overview
Although being used for several decades, interstitial brachytherapy remains a modern radiotherapeutic method. Over the time, it has been highly improved, including the latest technologies. Its broad use has been facilitaed by the use of high dose rate (HDR) afterloadings. The method is fast and fairly inexpensive. Its prons include, in particular, a possibility to apply a dose, in addition to external radiotherapy, directly into the tumor region or its focus, which may improve treatment success rates in patients with localized tumors.
The commonest diagnoses, where interstitial brachytherapy is employed, include the following: breast carcinomas, soft tissue sarcomas, head and neck tumors, gynaecological tumors, penile and anal tumors and prostate tumors.
In the article, the authors aimed to highlight potential and benefits of intersitital brachytherapy in individaual diagnoses. Only multidisciplinary management of these patients may improve their prognosis or quality of life.
Key words:
interstitial brachytherapy – HDR brachytherapy
Sources
1. Abbe, R. Notes on the physiologic and therapeutic action of radium. Wash. Med. Ann., 2: 363–377, 1904.
2. Dominici, H., Barcat, J. L‘action thérapeutique du radium sur les néoplasies. Arch. Elect. Méd., 16: 655–663, 1908.
3. Sahatchiev, A., Krov, S., Tcheretchanski, P., Moushmov, M. Résultats de la curiethérapie interstitielle du cancer de la vessie. Ann. Radiol., 14: 643–648; 1971.
4. Wallace, D. M., Stapleton, J. E., Turner, R. C. Radioactive tantalum wire implantation as a method of treatment for early carcinoma of the bladder. Br. J. Radiol., 25: 421–424; 1952.
5. Williams, G. B., Trott, P. A., Bloom, H. Carcinoma of the bladder treated by interstitial irradiation. Br. J. Urol. 53: 221–224, 1981.
6. Pizzi, G. B., Calzavara, F., Cauzzo, C., Zorat, P. L. Endocuriethérapie du cancer de la vessie. Proposition d’une nouvelle technique par fils de 192 Iridium en tubes de Cyponil. J. Radiol., 60: 715–718, 1979.
7. Fisher, E. R., Digram, J., Tan-Chiu, E., et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of protocol B-17. Cancer, 86: 429–438, 1999.
8. Holli, K., Saaristo, R., Idoly, J., et al. Lumpectomy with or without postoperative for breast cancer with favourable prognostic features: results of a randomized study. Br. J. Cancer, 84: 164–169, 2001.
9. Douglas, W. A., Vicini, F. A., Kuske, R. R., et al. Accelerated partial breast irradiation: an update report from the American Brachytherapy Society. Brachytherapy, 2: 124–130, 2003.
10. Kuske, R. R. Interstitial brachytherapy for breast cancer: technical issues and avoiding pitfalls. Radiother. Oncol., 71 (suppl. 2, abstr. 61): 31, 2004.
11. Akine, Y., et al. Stage I–II carcinoma of the anterior two-thirds of the tongue treated with different modalities: a retrospective analysis of 244 patients. Radiother. Oncol., 21: 24–28, 1991.
12. Benk, V., Mazeron, J. J., Grimard, J., et al. Comparison of curietherapy versus external irradiation combined with curie-therapy in stage II squamous cell carcinomas of the mobile tongue. Radiother. Oncol., 18: 229–247, 1990.
13. Bolla, M., Elbaze, D., Barthelme,, et al. Exclusive irradiation of carcinomas of the oral tongue and floor of mouth. Results about 457 cases. J. Eur. Radiother., 4: 64–73, 1983.
14. Fujita, M., Hirokawa, Y., Kashiwado, K., et al. Interstitial brachytherapy for stage I and II squamous cell carcinoma of the oral tongue: factors influencing local control and soft tissue complications. Int. J. Radiat. Oncol. Biol. Phys., 44: 767–775, 1999.
15. Gerbaulet, A., Haie-Meder, C., Marsiglia, H., et al. Role of brachytherapy in the treatment of Head & Neck cancer. Selectron Brachy. J., 3: 15–20, 1992.
16. Lefebvre, J. L., Coche-Dequeant, B., Buisset, E., et al. Management of early oral cavity cancer. Experience of Centre Oscar Lambret. Eur. J. Cancer, 30B: 216–220, 1994.
17. Pernot, M., Malissard, L., Hoffstetter, S. The study of tumoral, radiobiological and general health factors that influence results and complications in a series of 448 oral tongue carcinomas treated exclusively by irradiation. Int. J. Radiat. Oncol. Biol. Phys., 29: 673–679, 1994.
18. Yamazaki, H., Inoue, T., Yoshida, K., et al. Brachytherapy for early oral tongue cancer: low dose rate to high dose rate. J. Radiat. Res. (Tokyo), 44 (1): 37–40, 2003.
19. Inoue, T., Inoue, T., Yoshida, K., et al. Phase III trial of high- vs. low-dose-rate interstitial radiotherapy for early mobile tongue cancer. Int. J. Radiat. Oncol. Biol. Phys., 51 (1): 171–175, 2001.
20. Gerbaulet, A., Mazeron, J. J., Ash, D. Floor of Mouth Cancer. In: Gerbaulet, A., Potter, R., Mazeron, J. J., et al. The GEC ESTRO handbook of brachytherapy. ACCO, Leuven, Belgium, 253–264, 2002.
21. Gerbaulet, A., van Limbergen, E. Lip Cancer. In: Gerbaulet, A., Potter, R., Mazeron, J. J., et al. The GEC ESTRO handbook of brachytherapy. ACCO, Leuven, Belgium, 227–236, 2002.
22. Coucke, P. A., Guillemin, C. L., Mirimanoff, R. O. The role of radiotherapy in the treatment of soft tissue sarcoma. Bull. Cancer Radiother., 80: 13–26, 1993.
23. Marcus, S. J., Merino, M. J., Glatstein, E., et al. Long term outcome in 87 patients with low grade soft tissue sarcoma. Arch. Surg., 128: 1336–1343, 1993.
24. Rosenblatt, E., Meushar, N., Eidelman, M., et al. Low dose-rate interstitial brachytherapy in soft tissue sarcomas. Sarcoma, 3: 101–105, 1999.
25. Schray, M., Gunderson, L., Sim, F., et al. Soft tissue sarcoma – integration of brachytherapy, resection and external irradiation. Cancer, 66: 451–456, 1990.
26. Shiu, M., Hilaris, B., Harrison, L., et al. Brachytherapy and function saving resection of soft tissue sarcoma arising in the limb. Int. J. Radiat. Oncol. Biol. Phys., 21: 1485–1492, 1991.
27. Suit, H., Mankin, H., Wood, W., et al. Preoperative, intraoperative and postoperative radiation in the treatment of primary soft tissue sarcoma. Cancer, 55: 2659–2667, 1985.
28. Yang, J. C., Chang, A. E., Baker, A. R., et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J. Clin. Oncol., 16 (1): 197–203, 1998.
29. El-Denthy, M., Olivek, R., Hope-Stone, H., Blandy, J. Reappraisal of the role of radiotherapy and surgery in the management of carcinoma of the penis. Br. J. Urol., 56: 724–728, 1984.
30. Neave, F., Neal, A., Hoskin, P., Hope-Stone, H. Carcinoma of the penis: a retrospective review of treatment with iridium mould and external beam irradiation. Clin. Oncol., 5: 207–210, 1993.
31. Haile, K., Delclos, L. The place of radiation therapy in the treatment of carcinoma of the distal end of the penis. Cancer, 45: 1980–1984, 1980.
32. Fraley, E., Zhang, G., Saxama, R., Lange, P. Cancer of the penis. Prognosis and treatment plans. Cancer, 55: 1618–1624, 1985.
33. Narayana, A., Olney, L., Loening, S., et al. Carcinoma of the penis. Analysis of 219 cases. Cancer, 49: 2185–2191, 1982.
34. Gerbaulet, A., Lambin, P. Radiation therapy of cancer of the penis: indications, advantages and pitfalls. In: Crawford, D. E., Das, S. (eds) Penile, urethral, and scrotal cancer. The Urologic Clinics of North America. Philadelphia: W.B. Saunders, 325–332, 1992.
35. Mazeron, J. J., Langlois, D., Lobo, P. A., et al. Interstitial radiation therapy for carcinoma of the penis using iridium 192 wires: the Henri Mondor experience (1970–1979). Int. J. Radiat. Oncol. Biol. Phys., 10: 1891–1895, 1984.
36. Akimoto, T., Mitsuhashi, Takahashi, I., et al. Brachytherapy for penile cancer using silicon mould. Oncology, 54: 23–27, 1997.
37. Chaudhary, A. J., Ghosh, S., Bhalavat, R. L., et al. Interstitial brachytherapy in carcinoma of the penis. Strahlenther Oncol., 175: 17–20, 1999.
38. Delannes, M., Malavaud, V., Douchez, J., et al. Iridium-192 interstitial radiation therapy for squamous cell carcinoma of the penis. Int. J. Radiat. Oncol. Biol. Phys., 10: 1891–1895, 1984.
39. Guedea, F., Craven-Bartle, J., Caeles, J., et al. Interstitial radiotherapy using iridium 192 wires for carcinoma of the penis. Bull. Cancer Radiother., 78: 141–147, 1991.
40. Kanfir, K., Haie-Meder, C., Albano, M., et al. Outcome of patients treated with exclusive brachytherapy for carcinoma of the penis: the IGR experience. Radiother. Oncol., 55 (suppl 1, abstr. 36): 25, 2000.
41. Kiltie, A. E., Elwell, C., Close, H. J., Ash, D. V. Iridium-192 implantation for node-negative carcinoma of the penis: the Cookridge Hospital experience. Clin. Oncol., 12: 25–31, 2000.
42. Mazeron, J. J., Limbergen E. Anorectal cancer. In: The GEC ESTRO Handbook of Brachytherapy, A Gerbaulet, R Potter, JJ Mazeron, H Meertens, E Limbergen eds., ACCO, Leuven, Belgium, 2002, 505–514.
43. Berger, C., Felix-Faure, C., Chauvet, B., at al. Conservative treatment of anal canal carcinoma with external radiotherapy and interstitial brachytherapy, with or without chemotherapy: long term results. Cancer Radiother., 3 (6): 461–467, 1999.
44. Jacobson, G. Evolving concepts in the management of carcinoma of the vulva. In: Tobias, J., Thomas, P. Current Radiation Oncology, Arnold, 1998, 219–239.
45. Hacker, N. F., Eifel, P., McGuire, W. P., Wilkinson, E. J. Vulva. In: Hoskins, W. J., Perez, C. A., Young, R. C., edit. Principles and practice of gynecologic oncology. Philadelphia: Lippincott; 1992, 537–566.
46. Kelley, J. L., Burke, T. W., Tornos, C., Morris, M., Gershenson, D. M., Silva, E. G., Wharton, J. T. Minimally invasive vulvar carcinoma: an indication for conservative surgical therapy. Gynecol. Oncol., 44: 240–244, 1992.
47. Stehman, F. B., Bundy, B. N., Dvoretsky, P. M., Creasman, W. T. Early Stage I carcinoma of the vulva treated with ipsilateral superficial inguinal lymphadenectomy and modified radical hemivulvectomy: a prospective study of the Gynecologic Oncology Group. Obstet Gynecol., 79: 490–497, 1992.
48. Backstrom, A., Edsmyr, F., Wicklund, H. Radiotherapy of carcinoma of the vulva. Acta Obstet Gynecol. Scand., 51: 109–115, 1972.
49. Berven, E. G. E. Carcinoma of the vulva. Br. J. Radiol., 22: 498, 1949.
50. Daly, J. W., Million, R. R. Radical vulvectomy combined with elective node irradiation for TxN0 squamous carcinoma of the vulva. Cancer, 34: 161–165, 1974.
51. Frischbier, H. J., Thomsen, K. Treatment of cancer of the vulva with high-energy electrons. Am. J. Obstet. Gynecol., 111: 431–435, 1971.
52. Seeger, A. R., Windschall, A., Lotter, M., et al. The role of interstitial brachytherapy in the treatment of vaginal and vulvar malignancies. Strahlenther Onkol., 182 (3): 142–148, 2006.
53. Prempree, T., Amornmarn, R. Radiation treatment of recurrent carcinoma of the vulva. Cancer, 54: 1943–1949, 1984.
54. Hoffman, M., Greenberg, S., Greenberg, H., et al. Interstitial radiotherapy for the treatment of advanced or recurrent vulvar and distal vaginal malignancy. Am. J. Obstet. Gynecol., 162: 1278–1282, 1990.
Labels
Surgery Orthopaedics Trauma surgeryArticle was published in
Perspectives in Surgery
2007 Issue 10
Most read in this issue
- Biliary Ileus – A Rare Complication of Cholecystolithiasis
- Surgical Treatment of Breast Cancer in the Masaryk Memorial Cancer Institute
- Endovascular Treatment of Carotid Artery Stenosis with Cerebral Protection: 5-year Experience
- Tumorous Stem Cells – A Novel View in Oncology?